This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
On this month's EM Quick Hits podcast: Anand Swaminathan on update to ED management of postpartum hemorrhage, Nour Khatib on serotonin syndrome and its mimics, Katie Lin on an approach to recognition and management of severe TBI and brain herniation syndromes, Hans Rosenberg on the ED management of ulcerative colitis, Heather Cary on pediatric c-spine (..)
This pilot study aims to characterize utility of genetic testing in a pediatric and young adult neurovascular clinic.Methods:This was a single center cohort study of pediatric and young adult patients (age <25 years) with cerebrovascular conditions who underwent clinical genetic testing between 7/2023-7/2024.
Background:Studies describing outcomes of subarachnoid hemorrhage (SAH) in children are sparse. 1.02], p<0.001), higher NIS-Subarachnoid Hemorrhage Severity Score (NIS-SSS) (12.64 [4.21-37.95], Conclusion:Six of ten pediatric patients with SAH are discharged with excellent outcome with a 10% index hospitalization mortality.
In this month's EM Quick Hits podcast, Anand Swaminathan on postpartum hemorrhage, Justin Morgenstern on phenobarbital in pediatric status epilepticus, Michelle Klaiman on managed alcohol programs, Andrew Petrosoniak on traumatic cardiac arrest, Brit Long on cholangitis pearls and pitfalls and Bourke Tillman on ED approach to ARDS.
Background:Pediatric brain arteriovenous malformation (bAVM) patients often present with intracranial hemorrhage. While certain angioarchitectural features, such as aneurysms, deep venous drainage, a single draining vein, venous outflow stenosis, or small nidus size, increase hemorrhage risk, they do not fully predict it. cm (IQR: 1.8-4.2),
Objective:This study aims to evaluate the risk of cerebrovascular events in pediatric MMD during the preoperative waiting period, and explore the related risk factors and appropriate operation opportunities.Methods:This study is an observational cohort study, including 736 children with MMD from their initial visit until the completion of surgery.
IntroductionDue to the relative rarity of unruptured intracranial aneurysms (UIA) in the pediatric population, evidence regarding treatment modalities and clinical outcomes remains limited. days, p < 0.001), and lower rates of ischemic or hemorrhagic procedural‐related complications (1% vs. 4%, p = 0.010).ConclusionA
However, its utilization in the pediatric/young adult population is not well characterized.Methods:We queried the RAPID Insights database from 10/05/2018-09/29/2023 for unique patients between 2-25 years with a CTP. 307 (12.3%) cases had large vessel occlusions (LVOs) detected, and 77 (3.1%) had intracerebral hemorrhage (ICH).
Introductionintracranial dissecting aneurysm in pediatric age group is uncommon and very few studies are available comparing outcome following endovascular and surgery. years (range, 3–15 years), comprising 25% of all treated intracranial aneurysms in pediatric cases during the specified period. months (range, 6–55 months).ConclusionPediatric
Of the 38 (57% of the total) patients with clinical stroke at the time of presentation, 21 (55%) had right hemiplegia, 10 (26%) had left hemiplegia, and 7 (18%) presented without focal weakness.Conclusions:Moyamoya is an important cause of childhood stroke, and a risk factor for recurrent ischemic and hemorrhagic stroke throughout life.
Additionally, 38(45%) were ischemic and 34(40%) were hemorrhagic strokes.Of Neurologic events per imaging were 2(1, 2). MCA was affected in 22(26%), PCA 8(9%), ACA 8(9%), MCA+ACA 5(6%), and MCA+PCA 2(2%).
The HeartMate 3 is used for both short- and long-term support in pediatric and adult patients with severe left ventricular heart failure. It can be used while waiting for a heart transplant, to help the heart recover, or as a permanent solution when a transplant isn't an option. Use of these devices may cause serious injury or death.
Introduction:Structural changes following intracerebral hemorrhage (ICH) caused by ruptured brain vascular malformations (VMs) remain poorly understood. Lesion-network mapping with correlation to long-term outcome would elucidate the effects of this long-range neuroplasticity following pediatric ICH.
Patients were stratified based on radiographic outcomes: cured before the age of 18 (“pediatric-cured group”), cured after the age of 18, or not cured. Results:Forty-three adult patients were identified: 26 in the pediatric-cured group and 17 in the adult-cured group. Statistical analyses were conducted in R version 4.2.1.Results:Forty-three
Alteplase remained on formulary for pediatric stroke and other diagnoses. The system Alteplase hemorrhagic complication rate was 2.8% The legal department approved as our new standard of care for AIS. Guidelines and references were updated. A dosing table was created for rounding accuracy. compared to 2.5% for Tenecteplase.
5) Myocardial contusion (edema and hemorrhage in the myocardium) which may result in dysrhythmias, blocks (especially RBBB as here), and poor cardiac contractility, including wall motion abnormalities. Localized bleeding from contusion could cause hemopericardium even without rupture.
In this pediatric study, it was 71% successful and better than amiodarone. Procainamide is another reasonable solution to the problem. It does not block the AV node but does slow phase 0 of depolarization, which will also frequently break the re-entrant cycle.
Introduction:Cerebral cavernous malformations (CCMs) in children are associated with focal seizures, intracranial hemorrhage, and neurologic deficits, impacting quality of life (QoL). Conclusion:Psychological and social functioning domains, particularly experiences in pain and relationships, were impacted in the pediatric CCM population.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
125 
Let's personalize your content